Not checked for notices yet.
FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
Timothy S. Heuer, Richard Ventura, Kasia Mordec and 4 more
EBioMedicine · 2017
doi:10.1016/j.ebiom.2016.12.012
Cited by papers we hold 4
- Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics · 2023No notice
- Clinical development of metabolic inhibitors for oncology · 2022No notice
- Protein palmitoylation in cancer: molecular functions and therapeutic potential · 2022No notice
- Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.